
The partnership will provide financial support and strengthen early detection and intervention efforts

The new ‘Brain Health Matters’ campaign urges the public to prioritise brain health

More than 55 million people worldwide are currently living with the neurodegenerative disease

An estimated 982,000 people in the UK are currently living with the neurodegenerative disease

The neurodegenerative disorder accounts for up to 75% of the 982,000 dementia cases in the UK

Frontotemporal dementia accounts for less than one in 30 cases of the neurodegenerative disorder

The new risk factors identified are untreated vision loss and high low-density lipoprotein

Shingrix reduced dementia diagnoses by 17% compared to Merck & Co’s Zostavax after six years

Around a third of people living with dementia in England have not received a diagnosis

The most common form of dementia accounts for up to 80% of all cases

The neurodegenerative condition currently affects nearly ten million people worldwide

The company is seeking approval of donanemab to treat patients with early stages of the disease